DigitalCommons@UNMC

Title

Trefoil Factor(s) and CA19.9: A Promising Panel for Early Detection of Pancreatic Cancer

Authors

Rahat Jahan, University of Nebraska Medical CenterFollow
Koelina Ganguly, University of Nebraska Medical CenterFollow
Lynette M. Smith, University of Nebraska-LincolnFollow
Pranita Atri, University of Nebraska Medical CenterFollow
Joseph Carmicheal, University of Nebraska Medical CenterFollow
Yuri Sheinin, University of Nebraska Medical CenterFollow
Satyanarayana Rachagani, University of Nebraska Medical CenterFollow
Gopalakrishnan Natarajan, University of Nebraska Medical CenterFollow
Randall E. Brand, University of Pittsburgh
Muzafar A. Macha, University of Nebraska Medical CenterFollow
Paul M. Grandgenett, University of Nebraska Medical CenterFollow
Sukhwinder Kaur, University of Nebraska Medical CenterFollow
Surinder K. Batra, University of Nebraska Medical CenterFollow

Document Type

Article

Journal Title

EBioMedicine

Publication Date

2019

Abstract

BACKGROUND: Trefoil factors (TFF1, TFF2, and TFF3) are small secretory molecules that recently have gained significant attention in multiple studies as an integral component of pancreatic cancer (PC) subtype-specific gene signature. Here, we comprehensively investigated the diagnostic potential of all the member of trefoil family, i.e., TFF1, TFF2, and TFF3 in combination with CA19.9 for detection of PC.

METHODS: Trefoil factors (TFFs) gene expression was analyzed in publicly available cancer genome datasets, followed by assessment of their expression in genetically engineered spontaneous mouse model (GEM) of PC (KrasG12D; Pdx1-Cre (KC)) and in human tissue microarray consisting of normal pancreas adjacent to tumor (NAT), precursor lesions (PanIN), and various pathological grades of PC by immunohistochemistry (IHC). Serum TFFs and CA19.9 levels were evaluated via ELISA in comprehensive sample set (n = 362) comprised of independent training and validation sets each containing benign controls (BC), chronic pancreatitis (CP), and various stages of PC. Univariate and multivariate logistic regression and receiver operating characteristic curves (ROC) were used to examine their diagnostic potential both alone and in combination with CA19.9.

FINDINGS: The publicly available datasets and expression analysis revealed significant increased expression of TFF1, TFF2, and TFF3 in human PanINs and PC tissues. Assessment of KC mouse model also suggested upregulated expression of TFFs in PanIN lesions and early stage of PC. In serum analyses studies, TFF1 and TFF2 were significantly elevated in early stages of PC in comparison to benign and CP control group while significant elevation in TFF3 levels were observed in CP group with no further elevation in its level in early stage PC group. In receiver operating curve (ROC) analyses, combination of TFFs with CA19.9 emerged as promising panel for discriminating early stage of PC (EPC) from BC (AUC

INTERPRETATION: In silico, tissue and serum analyses validated significantly increased level of all TFFs in precursor lesions and early stages of PC. The combination of TFFs enhanced sensitivity and specificity of CA19.9 to discriminate early stage of PC from benign control and chronic pancreatitis groups.

ISSN

2352-3964

DOI Link

10.1016/j.ebiom.2019.03.056

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.

Recommended Citation

Jahan, Rahat; Ganguly, Koelina; Smith, Lynette M.; Atri, Pranita; Carmicheal, Joseph; Sheinin, Yuri; Rachagani, Satyanarayana; Natarajan, Gopalakrishnan; Brand, Randall E.; Macha, Muzafar A.; Grandgenett, Paul M.; Kaur, Sukhwinder; and Batra, Surinder K., "Trefoil Factor(s) and CA19.9: A Promising Panel for Early Detection of Pancreatic Cancer" (2019). Journal Articles: Biochemistry & Molecular Biology. 120.
https://digitalcommons.unmc.edu/com_bio_articles/120